Literature DB >> 32819183

16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

Ricard Cervera1, Ignasi Rodríguez-Pintó2, Kim Legault3, Doruk Erkan4.   

Abstract

The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) met again on occasion of the 16th International Congress on Antiphospholipid Antibodies (aPL) that was held in Manchester, England, in September 2019. Its aims were to assess the up-to-date knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors, and treatment of CAPS. This article summarizes the main aspects that were presented during the Task Force meeting at that Congress.

Entities:  

Keywords:  Anticardiolipin antibodies; antiphospholipid syndrome; catastrophic antiphospholipid syndrome

Mesh:

Substances:

Year:  2020        PMID: 32819183     DOI: 10.1177/0961203320951260

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

Review 1.  An Update on Antiphospholipid Syndrome.

Authors:  Eleni Xourgia; Maria G Tektonidou
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

Review 2.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

Review 3.  Clinical Management of Thrombotic Antiphospholipid Syndrome.

Authors:  Nor Rafeah Tumian; Beverley J Hunt
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

Review 4.  Diagnosis and treatment of thrombotic microangiopathy.

Authors:  Gemma L Thompson; David Kavanagh
Journal:  Int J Lab Hematol       Date:  2022-09       Impact factor: 3.450

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.